Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
WALTHAM, Mass., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of...
News
Eloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria
Podocyte Exact Morphology Procedure Results Podocyte Exact Morphology Procedure ResultsELX-02 treatment improved podocyte foot process effacement in all three patients...
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
Topline data results from the STRIDE study are expected in December 2023IRVINE, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Reneo...
MediWound Deploys NexoBrid® for Emergency Supply
YAVNE, Israel, Oct. 09, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic...
BridgeBio Pharma Shares Positive Long-Term Data from an Ongoing Phase 2 Study, which Support the Potential Use of Glycosylated Alpha-dystroglycan (⍺DG) Levels as a Surrogate Endpoint in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
- Early assessment of increased glycosylated ⍺DG levels at 3 months predicted subsequent ambulatory improvements at 9 months, supporting the...
RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer
SYDNEY, Australia, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products...
Virbac will enter the fast-growing poultry vaccines segment in India
Virbac announces the signing of an agreement to acquire Globion, a leading Indian poultry vaccines specialist. This transaction will bolster...
Advanced Health Intelligence to provide Biometric Health Screening in new Collaboration between Bearn and OnCore Innovations Inc.
HighlightsAHI partner Bearn LLC signs new collaboration with OnCore Innovations Inc.AHI biometrics to be used in Bearn and OnCore platform.OnCore...
New Safety Data Suggests SPRAVATO®▼ (Esketamine Nasal Spray) is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder
Beerse, Belgium, Oct. 08, 2023 (GLOBE NEWSWIRE) -- The new safety data is from the ESCAPE-TRD Phase 3b study1Additional findings...
New Safety Data Suggests SPRAVATO®▼ (Esketamine Nasal Spray) is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder
Beerse, Belgium, Oct. 08, 2023 (GLOBE NEWSWIRE) -- The new safety data is from the ESCAPE-TRD Phase 3b study1Additional findings...
Scilex Holding Company Retains Warshaw Burstein, LLP and Christian Attar Law to Investigate Potential Naked Short Selling, Short Positions, Stock Lending Program Activities and Market Manipulation of Its Stock Price
PALO ALTO, Calif., Oct. 07, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Clinical Trial for SB15, a Proposed Biosimilar to Eyleaⁱ (Aflibercept), at EURETINA 2023
Switching study conducted to evaluate whether switching from reference aflibercept to SB15 maintains comparable clinical efficacy and safetyPost-hoc analysis demonstrates...
Bicycle Health Commends U.S. Drug Enforcement Administration as It Extends Telemedicine Rule Through the End of 2024
This decision will continue to protect thousands of patients across the U.S. who access care for opioid use disorder via...
Goodness Growth Holdings and Grown Rogue International Announce the Completed Issuance of Warrants
Goodness Growth and Grown Rogue each issued warrants to the other to purchase listed shares Issuances were announced in May...
Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio
Special dividend estimated to be $1.5118 per share Payment of special dividend conditioned upon closing of merger, which is subject...
Emergency Care Partners and Its Louisiana Partner Ascension Emergency Physicians to Provide Emergency Medicine Services at Our Lady of the Lake Assumption Community Hospital
NAPOLEONVILLE, LA / ACCESSWIRE / October 6, 2023 / Emergency Care Partners (ECP) and local partner Ascension Emergency Physicians (AEP)...
CENTR Announces Departure with CBD Distributor
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or...
Defence to Present Three of Its Leading Products at the Upcoming Festival of Biologics in Basel, Switzerland
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
American Family Care Launches ‘Be an In[FLU]encer’ Drive for 2023 Flu Season
Nation's Leading Urgent Care Provider Advocates for Early Flu Vaccination with Interactive CampaignBIRMINGHAM, AL / ACCESSWIRE / October 6, 2023...
Digital Health Solution, Dentistry.One, Bridges the Gap Between Dental and Medical Care for Improved Health and Lower Costs – Visit Us at HLTH 2023
Booth #2450-22 (DiMe Virtual First Care Pavilion) and Booth #4950-5 (CareQuest Systemic Health Pavilion)METUCHEN, N.J.--(BUSINESS WIRE)--Dentistry.One, a virtual-first dental care...